Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: a case report.
Chan
Yiu-Chung
YC
Miller
Karla M
KM
Shaheen
Natalie
N
Votolato
Nicholas A
NA
Hankins
Mary Beth
MB
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D003024:Clozapine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D016651:Lithium Carbonate / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000209:etiology*; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D014227:Triazines; D016651:Lithium Carbonate; D014635:Valproic Acid; D003024:Clozapine; D000077213:Lamotrigine